Purchases and Sales Made in Q3 2021 in Vertex Pharmaceuticals Inc (VRTX)
This table provides information about the institutional ownership of Vertex Pharmaceuticals Inc (VRTX) during Q3 2021. The information is specifically focused on institutions that hold shares of VERTEX PHARMACEUTICALS INC .
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 15, 2021
Q3 2021
|
Rokos Capital Management LLP
London, X0 |
SELL
|
- |
-259KClosed |
$46.9M - $52.5M
|
0
$0
|
|
|
Nov 12, 2021
Q3 2021
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-266K- 16.47% |
$48.3M - $54M
|
1.35M
$550M
|
|
|
Nov 15, 2021
Q3 2021
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-292K- 27.19% |
$52.9M - $59.2M
|
781K
$318M
|
|
|
Nov 12, 2021
Q3 2021
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
SELL
|
- |
-324KClosed |
$58.8M - $65.8M
|
0
$0
|
|
|
Nov 08, 2021
Q3 2021
|
Congress Asset Management CO
|
SELL
|
- |
-338K- 98.79% |
$61.2M - $68.5M
|
4.12K
$1.68M
|
|
|
Nov 12, 2021
Q3 2021
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-386K- 16.94% |
$70M - $78.3M
|
1.89M
$770M
|
|
|
Nov 15, 2021
Q3 2021
|
Capital International Investors
Los Angeles, CA |
SELL
|
- |
-599K- 13.18% |
$109M - $122M
|
3.95M
$1.61B
|
|
|
Nov 12, 2021
Q3 2021
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-1.44M- 51.36% |
$261M - $293M
|
1.37M
$556M
|
|
|
Nov 16, 2021
Q3 2021
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-2.15M- 50.22% |
$391M - $437M
|
2.13M
$869M
|
|
|
Nov 15, 2021
Q3 2021
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-2.2M- 26.58% |
$400M - $448M
|
6.09M
$2.48B
|
|
|
Nov 05, 2021
Q3 2021
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-2.55MClosed |
$462M - $517M
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-7.4M- 56.5% |
$1.34B - $1.5B
|
5.7M
$2.32B
|